A new cytokine target for chronic obstructive pulmonary disease?
作者信息
Bernhagen Jürgen
机构信息
Chair of Vascular Biology, Institute for Stroke and Dementia Research (ISD), Klinikum der Universität München (KUM), Ludwig-Maximilians-University (LMU), 81377 Munich, Germany; Munich Cluster for Systems Neurology (SyNergy), 81377 Munich, Germany; Munich Heart Alliance, 80802 Munich, Germany.
出版信息
EBioMedicine. 2021 Jul;69:103479. doi: 10.1016/j.ebiom.2021.103479. Epub 2021 Jul 10.
Abstract
摘要
相似文献
1
A new cytokine target for chronic obstructive pulmonary disease?
EBioMedicine. 2021 Jul;69:103479. doi: 10.1016/j.ebiom.2021.103479. Epub 2021 Jul 10.
2
The cytokine network in chronic obstructive pulmonary disease.
Am J Respir Cell Mol Biol. 2009 Dec;41(6):631-8. doi: 10.1165/rcmb.2009-0220TR. Epub 2009 Aug 28.
3
The cytokine network in asthma and chronic obstructive pulmonary disease.
J Clin Invest. 2008 Nov;118(11):3546-56. doi: 10.1172/JCI36130.
4
Cytokines in chronic obstructive pulmonary disease.
Eur Respir J Suppl. 2001 Dec;34:50s-59s.
5
6
Chronic obstructive pulmonary disease and cytokines.
Crit Care Nurs Q. 2008 Oct-Dec;31(4):321-3. doi: 10.1097/01.CNQ.0000336818.27418.cd.
7
Hydrogen-rich saline inhibits tobacco smoke-induced chronic obstructive pulmonary disease by alleviating airway inflammation and mucus hypersecretion in rats.
Exp Biol Med (Maywood). 2017 Sep;242(15):1534-1541. doi: 10.1177/1535370217725249. Epub 2017 Aug 10.
8
[Biochemical and immunological markers of osteoporosis in patients with chronic obstructive pulmonary disease].
Klin Med (Mosk). 2002;80(10):31-5.
9
Serum cytokine profiles in patients with chronic obstructive pulmonary disease associated pulmonary hypertension identified using protein array.
Cytokine. 2018 Nov;111:342-349. doi: 10.1016/j.cyto.2018.09.005. Epub 2018 Sep 28.
10
Cytokines and statin therapy in chronic obstructive pulmonary disease patients.
Scand J Clin Lab Invest. 2018 Nov-Dec;78(7-8):533-538. doi: 10.1080/00365513.2018.1514464. Epub 2018 Oct 2.
引用本文的文献
1
Analysis of immune characteristics and inflammatory mechanisms in COPD patients: a multi-layered study combining bulk and single-cell transcriptome analysis and machine learning.
Front Med (Lausanne). 2025 Jul 21;12:1592802. doi: 10.3389/fmed.2025.1592802. eCollection 2025.
2
Proinflammatory Cytokines in Chronic Respiratory Diseases and Their Management.
Cells. 2025 Mar 9;14(6):400. doi: 10.3390/cells14060400.
3
An atypical atherogenic chemokine that promotes advanced atherosclerosis and hepatic lipogenesis.
Nat Commun. 2025 Mar 7;16(1):2297. doi: 10.1038/s41467-025-57540-z.
4
1-DNJ Alleviates Obesity-Induced Testicular Inflammation in Mice Model by Inhibiting IKKβ/ NF-kB Pathway.
Reprod Sci. 2024 Jul;31(7):2103-2113. doi: 10.1007/s43032-024-01502-1. Epub 2024 Mar 7.
5
The molecular mechanism of ferroptosis and its role in COPD.
Front Med (Lausanne). 2023 Jan 6;9:1052540. doi: 10.3389/fmed.2022.1052540. eCollection 2022.
6
Budesonide/glycopyrronium/formoterol fumarate triple therapy prevents pulmonary hypertension in a COPD mouse model via NFκB inactivation.
Respir Res. 2022 Jun 27;23(1):173. doi: 10.1186/s12931-022-02081-y.
本文引用的文献
1
D-dopachrome tautomerase contributes to lung epithelial repair via atypical chemokine receptor 3-dependent Akt signaling.
EBioMedicine. 2021 Jun;68:103412. doi: 10.1016/j.ebiom.2021.103412. Epub 2021 Jun 4.
2
Regenerative pharmacology for COPD: breathing new life into old lungs.
Thorax. 2019 Sep;74(9):890-897. doi: 10.1136/thoraxjnl-2018-212630. Epub 2019 Apr 2.
3
Macrophage Migration Inhibitory Factor (MIF)-Based Therapeutic Concepts in Atherosclerosis and Inflammation.
Thromb Haemost. 2019 Apr;119(4):553-566. doi: 10.1055/s-0039-1677803. Epub 2019 Feb 4.
4
A functional macrophage migration inhibitory factor promoter polymorphism is associated with reduced diffusing capacity.
Am J Physiol Lung Cell Mol Physiol. 2019 Feb 1;316(2):L400-L405. doi: 10.1152/ajplung.00439.2018. Epub 2018 Dec 6.
5
Targeting cytokines to treat asthma and chronic obstructive pulmonary disease.
Nat Rev Immunol. 2018 Jul;18(7):454-466. doi: 10.1038/s41577-018-0006-6.
6
Targeting distinct tautomerase sites of D-DT and MIF with a single molecule for inhibition of neutrophil lung recruitment.
FASEB J. 2014 Nov;28(11):4961-71. doi: 10.1096/fj.14-256636. Epub 2014 Jul 11.
7
Macrophage migration inhibitory factor deficiency in chronic obstructive pulmonary disease.
Am J Physiol Lung Cell Mol Physiol. 2014 Mar 15;306(6):L487-96. doi: 10.1152/ajplung.00284.2013. Epub 2014 Jan 17.
8
The D-dopachrome tautomerase (DDT) gene product is a cytokine and functional homolog of macrophage migration inhibitory factor (MIF).
Proc Natl Acad Sci U S A. 2011 Aug 23;108(34):E577-85. doi: 10.1073/pnas.1102941108. Epub 2011 Aug 4.
9
MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment.
Nat Med. 2007 May;13(5):587-96. doi: 10.1038/nm1567. Epub 2007 Apr 15.
10
Macrophage migration inhibitory factor: a regulator of innate immunity.
Nat Rev Immunol. 2003 Oct;3(10):791-800. doi: 10.1038/nri1200.
Zotero 插件